-
BRG-1/SMARCA4 (BSB-154)
BRG-1/SMARCA4 (BSB-154)
- 中文名称：
- BRG-1/SMARCA4 (BSB-154)
- 英文名称：
- BRG-1/SMARCA4 (BSB-154)
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA59358
- 规格：
- 5 Slides|3 mL (RTU)|0.1 mL (Concentrate)|7 mL (RTU)|0.5 mL (Concentrate)
- 保存建议：
- Store at 2-8 degree C (Control Slides: Store at 20-25 degree C)
- 货期：
- 6-8周
- 来源宿主：
- Mouse
- 反应种属：
- Human, Mouse, Rat
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 其他：
克隆性:Monoclonal
同型:IgG1
克隆号:[BSB-154]
特异性:N/A
纯度:N/A
形式：Paraffin, Frozen
BRG-1/SMARCA4 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH7.5, containing BSA and sodium azide as a preservative.
浓度：N/A
- 说明书：
Brahma-related gene-1 (BRG-1) protein is encoded by the gene SMARCA-4, which is localized on chromosome 19. BRG-1 is the core catalytic ATPase subunit of the SWItch/sucrose non-fermentable (SWI/SNF) complex. SWI/SNFs are a member of the family of ATP-dependent chromatin-remodeling complexes and the function of SWI/SNFs is to facilitate the transcriptional activation or repression of target genes. BRG-1 is essential for DNA repair, differentiation, and organ development. The molecular weight of the BRG-1 subunit is approximately 185 kDa.
There are several studies that suggest the involvement of BRG-1 in different cancer types. It was found that the loss of BRG-1 antibody expression occurs in a portion of tested cancers types, including Breast, Colon, Head/Neck, Ovarian, Liver and Renal Cell Cancer. On the contrary, overexpression of BRG-1 was found in Breast, Colorectal, and Prostate Cancer, as well as Melanoma and Neuroblastoma. An IHC analysis of BRG-1 in Non-Small Cell Lung Cancer (NSCLC) patients revealed that the survival rate of BRG-1 negative patients was 0%, when compared to BRG-1 positive patients, indicating the prognostic value of BRG-1 as a biomarker. Other IHC studies found that the loss of BRG-1 protein expression highly correlates with Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT), suggesting BRG-1 as a test marker for SCCOHT.
